You’ve probably seen the Zepbound headlines: people losing 20% of their body weight, before-and-after photos everywhere. It’s fair to wonder how much of that is real and how much you could actually expect for yourself.
This post walks through what the SURMOUNT clinical trials found, what the numbers mean for a real person in Orange County, and how quickly results tend to show up.
In a nutshell: In the SURMOUNT-1 trial, adults without diabetes lost an average of about 15% to 21% of their body weight over roughly 72 weeks on Zepbound (tirzepatide), depending on the dose. Weight loss usually starts within the first month and builds steadily over a year or more. Results vary widely from person to person, and Zepbound is a prescription medication that requires medical evaluation and ongoing supervision. Diet, movement, and dose all shape your outcome.
How much weight did people lose on Zepbound in the trials?
In SURMOUNT-1, the main trial in adults with obesity but without type 2 diabetes, average weight loss over about 72 weeks ranged from roughly 15% on the lowest maintenance dose to about 21% on the highest dose. For someone who weighs 220 pounds, that’s a range of about 33 to 46 pounds on average.
Those are averages, which means some people lost more and some lost less. In the trial, more than half of participants on the higher doses lost at least 20% of their body weight. A separate trial, SURMOUNT-2, studied adults who also had type 2 diabetes; average loss there was a bit lower, closer to 12% to 15%, since diabetes tends to slow weight loss.
- 5 mg dose: about 15% average body-weight loss
- 10 mg dose: about 19% average body-weight loss
- 15 mg dose: about 21% average body-weight loss
How does Zepbound work to produce these results?
Zepbound works by mimicking two gut hormones, GLP-1 and GIP, that regulate appetite and blood sugar. Its active ingredient is tirzepatide. By acting on both hormone pathways, it slows how fast your stomach empties and signals fullness to your brain, so you feel satisfied on less food and think about food less often.
That dual action is what sets tirzepatide apart from single-hormone GLP-1 medications. It’s the same reason the average weight-loss numbers in the tirzepatide trials tend to run higher than those seen with semaglutide-based medications. You can read more about how this whole medication class works on our GLP-1 overview.
How soon will I see results on Zepbound?
Most people notice reduced appetite within the first week or two, and the scale usually starts moving within the first month. In the trials, weight came off steadily rather than all at once, with the biggest drops happening over the first several months and continuing gradually toward the 72-week mark.
The typical timeline
- Weeks 1-4: lower appetite, early loss of a few pounds as the starting dose takes effect
- Months 2-6: the fastest, most noticeable weight loss as your dose steps up
- Months 6-18: continued but slower loss until you reach a plateau
Zepbound is titrated, meaning your clinician starts you low and raises the dose gradually to limit side effects like nausea. That slow ramp is part of why results build over months instead of appearing overnight.
Why do results vary so much from person to person?
Genetics, starting weight, dose tolerance, and daily habits all influence how much you lose. Two people on the same dose can have meaningfully different results. The trial averages are a useful benchmark, not a promise, and roughly one in ten participants lost less than 5% of their body weight.
What you do alongside the medication matters. People who paired Zepbound with a modest calorie reduction and regular activity tended to hold their results better. Protecting muscle also matters, since rapid loss can strip lean mass along with fat. We cover practical steps in our guide to preventing muscle loss on GLP-1 medications.
What happens to results if I stop taking Zepbound?
Weight tends to return after stopping, which is worth understanding up front. In a trial where people came off tirzepatide after reaching their lower weight, many regained a significant portion of what they’d lost over the following year. Obesity is a chronic condition, so the medication manages it rather than curing it.
This is why most clinicians treat Zepbound as a long-term tool with a plan for what comes next, whether that’s a maintenance dose, a transition strategy, or building habits that hold. Any decision to start, adjust, or stop should happen with your prescriber, not on your own.
How does Zepbound compare to semaglutide for weight loss?
On average, tirzepatide (Zepbound) produced greater weight loss than semaglutide (Wegovy) in a head-to-head trial, but both are effective and the right choice depends on you. Semaglutide averaged around 15% weight loss in its own trials, versus the higher tirzepatide figures above. Cost, insurance coverage, side effects, and how your body responds all factor in.
If you’re weighing your options, our guide to semaglutide in Orange County lays out the real differences so you can bring informed questions to your consult.
FAQ
How much weight can I lose in a month on Zepbound?
Early monthly loss is often a few pounds while you’re on the starting dose, then it can increase as your dose steps up. Trial results averaged roughly 1% to 1.5% of body weight per month over the long run, though individual results vary.
Is 20% weight loss realistic on Zepbound?
It’s realistic for many people on the higher doses; more than half of high-dose participants in SURMOUNT-1 lost at least 20%. But it’s an average outcome, not a guarantee, and it typically takes over a year to get there.
Do Zepbound results plateau?
Yes. Most people reach a plateau somewhere between 12 and 18 months as the body adjusts. Reaching a plateau is expected and usually marks the shift from active loss to maintenance rather than a sign the medication stopped working.
Does Zepbound work without diet and exercise?
Zepbound can produce weight loss on its own by reducing appetite, but results are stronger and more durable when paired with sensible eating and activity. Trial participants received lifestyle guidance alongside the medication.
Is Zepbound safe long term?
Zepbound has been studied over 72 weeks and longer with a well-characterized safety profile, most commonly mild-to-moderate nausea, diarrhea, or constipation. It’s a prescription medication that requires medical evaluation and ongoing supervision to use safely.
Who is not a good candidate for Zepbound?
People with a personal or family history of medullary thyroid cancer, certain endocrine conditions, or specific pregnancy plans may not be candidates. A clinician reviews your health history to determine whether it’s appropriate for you.
Medically reviewed by the clinical team at OC Weight Loss and Medspa. Last updated July 2026.
See what your own numbers could look like
The trial averages are encouraging, but the number that matters is yours, and that starts with a real conversation about your health, your history, and your goals. Our clinicians build supervised plans around the whole picture, whether that’s Zepbound or another approach through our medical weight loss program. Bring your questions and we’ll map out what’s realistic for you.
Book a Free Consultation